Salim Chahin

Medicine & Life Sciences

1. Multiple Sclerosis 100%
2. Neuromyelitis Optica 23%
3. Acute Disseminated Encephalomyelitis 20%
4. Myelin-Oligodendrocyte Glycoprotein 20%
5. Vaccines 17%
6. Vaccination 14%
7. Antibodies 13%
8. Multicenter Studies 12%
9. Fatigue 12%
10. Veins 12%
11. Dimethyl Fumarate 11%
12. Cost Sharing 10%
13. Natalizumab 10%
14. Aquaporin 4 10%
15. Medicare 10%
16. Hepatitis Delta Virus 10%
17. Vaccine Immunogenicity 10%
18. Fingolimod Hydrochloride 9%
19. Progressive Multifocal Leukoencephalopathy 9%
20. Tumor Necrosis Factor Inhibitors 9%
21. Severe Acute Respiratory Syndrome 9%
22. Neurologists 9%
23. Coronavirus 9%
24. Immunosuppressive Agents 8%
25. Non-Randomized Controlled Trials 8%
26. Singapore 8%
27. Immunosuppression 8%
28. Chronic Disease 7%
29. Lymphocyte Count 7%
30. Neuropsychological Tests 7%
31. Neurology 7%
32. Pediatrics 7%
33. Nervous System 7%
34. SARS Virus 7%
35. Visual Acuity 6%
36. Contracts 6%
37. Ocular Vision 6%
38. Japan 5%
39. China 5%
40. Demyelinating Diseases 5%
41. Incidence 5%
42. Messenger RNA 5%
43. Health Care Outcome Assessment 5%